All articles tagged: Malignant neoplasm of rectum (C20)
HealthDay
11 July at 04.04 PM
GLP-1 RAs May Reduce Risk for Some Obesity-Linked Cancers Versus Insulin in T2DFor patients with type 2 diabetes (T2D), glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a reduced risk for 10 of 13 obesity-associated cancers (OACs) compared with insulin, according to a study published online July 5 in JAMA Network Open.Lindsey Wang, from Case Western Reserve University School of Medicine |
Evalytics
19 March at 06.39 AM
A new way to screen for colon cancer may be on the horizon, study suggestsThe potential approval of the first blood test for colorectal cancer this year could mark a significant breakthrough in cancer detection, potentially increasing the number of diagnoses for the second-highest cause of cancer death in the United States. While experts emphasize that the test would not replace colonoscopies, it could offer a less invasive alternative and encourage more people to under |
|
HealthDay
11 January at 05.10 PM
Robotic Surgery Preferred for Most Colorectal Cancer SurgeriesRobotic surgery for colorectal cancer (CRC) offers an advantage over conventional laparoscopy by improving textbook outcomes for right colectomy (RC) and left colectomy (LC), according to a study recently published in the World Journal of Surgical Oncology.Emile Farah, M.D., from the University of Texas Southwestern (UTSW) Medica |
|
HealthDay
21 December at 11.08 PM
MSI-H Colorectal Cancer Rarely Recurs After Immunotherapy CessationMost patients with microsatellite instability-high (MSI-H) colorectal cancer do not have recurrence after cessation of immunotherapy treatment, according to a study published in the December issue of Cancer Research Communications.Kristen Simmons, M.D., from the Baylor College of Medicine in Houston, and colleagues reviewed records fr |
|
Evalytics
18 December at 06.06 PM
People who got colon cancer in their 20s or 30s describe what it was like and the signs that were ignoredThe NBC News article discusses the increasing cases of colon cancer in young adults and features personal stories of individuals who faced diagnostic challenges due to their age. It underscores the need for early detection and awareness of colon cancer symptoms in younger populations. |
|
HealthDay
28 November at 05.03 PM
Recent Decline in Risk for CRC Recurrence Seen in Stage I to III DiseaseFrom 2004 to 2019, the risk for recurrence of colorectal cancer (CRC) decreased in patients with stages I to III disease, according to a study published online Nov. 16 in JAMA Oncology to coincide with the annual meeting of the Danish Surgical Society, held from Nov. 16 to 17 in Copenhagen.Jesper Nors, M.D., from Aarhus University Hosp |
|
|
HealthDay
22 November at 10.44 PM
>10 Percent of FIT Are Unsatisfactory and Cannot Be ProcessedMore than 10 percent of fecal immunochemical tests (FIT) for colorectal cancer cannot be processed by a laboratory, and fewer than half complete a subsequent FIT within 15 months, according to a study published online Nov. 3 in Cancer Epidemiology, Biomarkers & Prevention.Po-Hong Liu, M.D., from the University of Texas Southweste |
|
HealthDay
07 November at 04.44 PM
Advanced Neoplasia Risk Increased at Upper Range of Negative FIT ValuesIndividuals in the upper range of fecal immunochemical test (FIT)-negative screening have an increased risk for advanced neoplasia (AN), according to a research letter published online Nov. 7 in the Annals of Internal Medicine.Tobias Niedermaier, Ph.D., from the German Cancer Research Center in Heidelberg, and colleagues provided a dose |
|
HealthDay
30 October at 03.39 PM
Risk-Adapted Starting Age of CRC Screening Varies by Sex, GeneticsRisk-adapted starting ages of screening vary by sex and polygenic risk score (PRS) among individuals at average risk for colorectal cancer (CRC), according to a study published online Oct. 25 in JAMA Network Open.Xuechen Chen, Ph.D., from the German Cancer Research Center in Heidelberg, and colleagues illustrated derivation of risk-adju |
MedScape
28 November at 01.50 AM
Sleep-Disordered Breathing Common After StrokeSleep-disordered breathing remains common after stroke, affecting 60% of patients and showing no decline in prevalence from 2010 to 2023, a new meta-analysis suggested. |
Medpage Today
24 November at 08.00 PM
IDH Inhibitor Activity in Brain Cancer Persists With Longer Follow-UpHOUSTON -- Progression-free survival (PFS) in IDH-mutant low-grade glioma remained twice as high in adults who received vorasidenib (Voranigo) after surgery versus placebo, according to a follow-up analysis of a pivotal clinical... |
Medical xPress
23 November at 01.50 PM
RNA editing is the next frontier in gene therapy—here's what you need to knowThe United States Food and Drug Administration has just approved the first-ever clinical trial that uses CRISPR-Cas13 RNA editing. Its aim is to treat an eye disease called wet age-related macular degeneration that causes vision loss in millions of older people worldwide. |
|
HealthDay
22 November at 04.44 PM
Semaglutide, Liraglutide May Reduce Hospitalization Risk for Alcohol Use DisorderSemaglutide and liraglutide are associated with a reduced risk for hospitalization due to alcohol use disorder (AUD), according to a study published online Nov. 13 in JAMA Psychiatry.Markku Lähteenvuo, M.D., Ph.D., from the University of Eastern Finland in Kuopio, and colleagues conducted an observational study in Sweden using data from |
|
Medpage Today
17 November at 10.31 PM
Two Treatments That Don't Work for OsteoarthritisWASHINGTON -- If you're looking for nonsurgical osteoarthritis (OA) treatments with fewer side effects than ordinary pain relievers, two randomized trials presented here with negative results should at least narrow your search... |
|
MedScape
11 November at 07.56 AM
Scoring System Could Mean Better Access to Lung TransplantScoring system could improve access for hard-to-match candidates due to height and blood type. |
|
|
|
Medical xPress
07 November at 07.50 AM
How key results could influence health policyThe results of some congressional races may foreshadow who will have outsize health policy influence in Congress next year. |
|
Medpage Today
05 November at 07.00 PM
Mpox Cases in Congo May Be StabilizingGOMA, Congo -- Some health officials say mpox cases in Congo appear to be "stabilizing" -- a possible sign that the main epidemic for which the World Health Organization (WHO) made a global emergency declaration in August... |
|
Medical xPress
02 November at 07.40 AM
Insulin resistance caused by sympathetic nervous system over-activation, a paradigm-shifting study findsRutgers Robert Wood Johnson Medical School and collaborating institutions have found that overnutrition leads to insulin resistance and metabolic disorders through increased activity of the sympathetic nervous system (SNS). The study shows that reducing SNS activity can prevent insulin resistance induced by a high-fat diet, suggesting a new understanding of how obesity causes insulin resistance. |
|
MedScape
31 October at 06.30 AM
Report: Rethink Race-Based Adjustments in Clinical ToolsThe slow adoption of race-neutral tools may harm patient care outcomes, according to a new report from the National Academies of Sciences, Engineering, and Medicine. |
Newsletter for Healtcare
Join over 1.2M subscribers and receive one weekly email.
